XClose

UCL Great Ormond Street Institute of Child Health

Home
Menu

Prof David Goldblatt

Prof David Goldblatt

Address

30 Guilford Street
London
WC1N 1EH

Appointments

  • Professor of Vaccinology and Immunology
    ICH Infect, Imm, Infla. & Physio Med
    UCL GOS Institute of Child Health

Joined UCL

1987-05-18

Professor Goldblatt has a long-standing interest in the immune response to vaccines and infectious diseases in childhood and has an active research programme in these areas with a focus on encapsulated bacteria. He is involved in collaborative research with colleagues in the United Kingdom, Africa, SE Asia and the USA.

Award year Qualification Institution
1991 PhD
Doctor of Philosophy
Medicine
University of London
1986 MRCP
Member of the Royal College of Physicians
Clinical Medicine
Royal College of Physicians
1983 MB.ChB
Bachelor of Medicine, Bachelor of Surgery
Clinical Medicine
University of Cape Town
Professor David Goldblatt is Professor of Vaccinology and Immunology and Head of the Immunobiology Unit at the Institute of Child Health, University College London as well as a Consultant Paediatric Immunologist at the Great Ormond Street Hospital for Children NHS Trust. He is the Director of Clinical Research and Development for the joint Institution where he is also Director of the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre and the Program Director (Child Health) for UCL's Academic Health Science Centre, UCL Partners. He obtained his medical degree from the University of Cape Town, South Africa, his Paediatric qualifications from the Royal College of Physicians (London) and a PhD in Immunology from the University of London, United Kingdom.
He is a regular advisor to the World Health Organisation (WHO) on bacterial conjugate vaccines and is Director of the WHO Reference Laboratory for Pneumococcal Serology based at the UCL Institute of Child Health in London. He served as a member of the United Kingdom Department of Health Joint Committee on Vaccines and Immunisation for 10 years (1997-2007) and still contributes to various sub-groups. He has served on the UK MRC Infection and Immunity Board, co-chaired the Wellcome Trust Immunology and Infectious Disease Funding Committee panel (2007-2010) and currently sits one of the Wellcome Trusts new Expert Review Groups (Immunology in Health and Disease).

Keywords

Chronic Granulomatous Disease|*|Immunodeficiency|*|Infectious diseases|*|Pneumonia|*|Vaccine